Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.
Strisciuglio C, et al. J Clin Gastroenterol. 2016.
GOALS: We conducted a case-control association analysis to establish the role of a common CB2 functional variant, Q63R, in the susceptibility to inflammatory bowel disease (IBD).
BACKGROUND: Endocannabinoids may limit intestinal inflammation through cannabinoid receptor 1 and/or 2 (CB1, CB2).
(Next News) A history of the American war on weed »
Related News
New Study Shows Cannabis Reduces Inflammatory ‘Storms’ Caused By Covid-19
New Study Shows Cannabis Reduces Inflammatory ‘Storms’ Caused By Covid-19 Lindsey Bartlett | Jan 21,Read More
What Caregivers Need to Know About Medical Marijuana
What Caregivers Need to Know About Medical Marijuana Amanda Singleton | December 21, 2020 MyRead More
Comments are Closed